(Q46297988)

21 December 2017

title

The ocular presentation of neurofibromatosis 2. (English)

1 reference

21 December 2017

author name string

Ragge NK

1

1 reference

21 December 2017

Baser ME

2

1 reference

21 December 2017

Riccardi VM

3

1 reference

21 December 2017

Falk RE

4

1 reference

21 December 2017

publication date

1 January 1997

1 reference

21 December 2017

published in

Eye

1 reference

21 December 2017

volume

11 ( Pt 1)

1 reference

21 December 2017

page(s)

12-18

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/eye.1997.3

exact match

0 references

cites work

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Ocular findings associated with neurofibromatosis type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Lens opacities in neurofibromatosis 2: further significant correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Ocular abnormalities in neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Screening for germ-line mutations in the NF2 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Germline mutations in the neurofibromatosis type 2 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Clinical and genetic patterns of neurofibromatosis 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Retinal hamartoma in neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Bilateral retinal hamartomas in neurofibromatosis type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Ocular fundus in neurofibromatosis type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5' part of the gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13, 1991. The Consensus Development Panel

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

Familial occurrence of combined pigment epithelial and retinal hamartomas associated with neurofibromatosis 2

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

Optic disk glioma in neurofibromatosis type 2.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

Isolated neurofibromas of the conjunctiva

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

Isolated Neurofibromas of the Conjunctiva

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

Retinal angiomatosis in a patient with neurofibromatosis.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

Lisch nodules in neurofibromatosis type 2. Case report

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

Ophthalmological screening for von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1997.3

7 January 2021

Identifiers

DOI

10.1038/EYE.1997.3

1 reference

21 December 2017

PubMed ID

9246269

1 reference

21 December 2017